Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-EN Version v2-FR
Language English French
Date Updated 2023-04-28 2021-07-15
Drug Identification Number 02296357 02296357
Brand name ACT ONDANSETRON ACT ONDANSETRON
Common or Proper name ONDANSETRON 8MG FC TAB ONDANSETRON 8MG FC TAB
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients ONDANSETRON ONDANSETRON
Strength(s) 8MG 8MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 10UD 10UD
ATC code A04AA A04AA
ATC description ANTIEMETICS AND ANTINAUSEANTS ANTIEMETICS AND ANTINAUSEANTS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-07-13 2021-07-13
Estimated end date Unknown Unknown
Actual end date 2023-04-27
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments